Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Next Science.
RELATED STOCKHEAD STORIES
News
Last Orders: What you might have missed on the ASX today
Health & Biotech
Superbugs will kill 22,000 Australians annually by 2040; but these stocks are trying to stop that
Director Trades
Directors’ Trades: It is ever too late to jump on the bandwagon?
Health & Biotech
This new antimicrobial resistance network could boost Recce, Botanix and Next Science
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Billionaire Walker just took another big stake in Next Science
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
MedAdvisor eyes off US health insurance market with new distribution deal
Health & Biotech
Health: Even bacteria fighter Next Science is feeling the coronavirus pinch
Health & Biotech
Health: Biofilm killer Next Science stays focused on the US market with four new product rollouts
IPO Watch
IPO Watch: Five of 2019’s IPO class are delivering 3x returns
IPO Watch
IPO Watch: The average 2019 IPO is up 52 per cent
IPO Watch
IPO Watch: Status quo holds, two new stocks join and four walk away
Health & Biotech
Health: ResApp popping bottles in the ice as cough app finally gets approval; shares fly
IPO Watch
IPO Watch: Tech and pot floats still on fire
IPO Watch
Quality over quantity: ASX IPO activity slowed sharply in the first half of the year
IPO Watch
